Menopause (Hyland’s)


Welcome to the PulseAid listing for the Menopause drug offered from Hyland’s. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.

LABELER NAME / MANUFACTURER: Hyland’s
NON-PROPRIETARY NAME: AMYL NITRITE, SANGUINARIA CANADENSIS ROOT, and LACHESIS MUTA VENOM
SUBSTANCE NAME: AMYL NITRITE; SANGUINARIA CANADENSIS ROOT; LACHESIS MUTA VENOM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, SOLUBLE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-03-01
END MARKETING DATE: 0000-00-00


Menopause HUMAN OTC DRUG Details:

Item DescriptionMenopause from Hyland’s
LABELER NAME: Hyland’s
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 3; 12([hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 1995-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54973-9113_72629595-5e70-499e-b794-106d6b9833ef
PRODUCT NDC: 54973-9113
APPLICATION NUMBER:

Other AMYL NITRITE; SANGUINARIA CANADENSIS ROOT; LACHESIS MUTA VENOM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hyland’sMenopause